Azenta inc..

Nov 30, 2023 · Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions ... Nov 21, 2023 · Open Filing by person (s) reporting owned shares of common stock in a public company >5% in PDF file. Open Filing by person (s) reporting owned shares of common stock in a public company >5% in XLS file. 3. Initial filing by director officer or owner of more than ten percent. Aug 31, 2023. Azenta Life Sciences offers two sample management software solutions designed to provide a centralized, reliable source of 24/7 information access to researchers and scientists: FreezerPro ® for focused sample management, and Limfinity ® Biobanking LIMS for sample management and LIMS workflows. Automated sample and compound storage ... The Azenta Life Sciences Tri-Coded sample tubes offer unequaled sample audit traceability, enabling sample tracking and data sharing between multiple users, labs, locations and automation capabilities. Designed and developed with broad compatibility in mind, these sample tubes perform without compromise in conjunction with automated barcode ...Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in 1x1 meetings at the 6th Annual Evercore ISI HealthCONx Conference in Miami, FL, on Wednesday, November 29, 2023. Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023.

Dec 1, 2023 · Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. Azenta Inc’s Stock Price as of Market Close. As of November 14, 2023, 4:00 PM, CST, Azenta Inc’s stock price was $54.45. Azenta Inc is up 13.89% from its previous closing price of $47.81. During the last market session, Azenta Inc’s stock traded between $46.23 and $48.25. Currently, there are 63.43 million shares of Azenta Inc stock ...

Feb 9, 2015 · Azenta has laboratories, biorepositories, and manufacturing facilities across the globe to assist in accelerating your discoveries. Please use the menu below to find the right location to support you. You can also reach out to us by filling out this form. Corporate Headquarters. 200 Summit Drive.

May 10, 2021 · CHELMSFORD, Mass., May 10, 2021 – Brooks Automation, Inc. (“Brooks”) (Nasdaq: BRKS) today announced its intention to separate its business into two independent, and publicly traded companies. The transaction is intended to be structured as a pro-rata distribution of shares to Brooks shareholders in a tax-efficient manner and will establish: Dec 1, 2023 · Currently, Azenta Inc does not have a price-earnings ratio. Azenta Inc’s trailing 12-month revenue is $665.1 million with a -2.1% net profit margin. Year-over-year quarterly sales growth most recently was 25.3%. Analysts expect adjusted earnings to reach $0.233 per share for the current fiscal year. Azenta Inc does not currently pay a dividend. Mar 21, 2023 · Azenta Investor Overview January 2023. 01/11/23. 41st Annual J.P. Morgan Healthcare Conference Presentation. 01/11/23. 25th Annual Needham Growth Conference Presentation. 11/14/22. Feb 3, 2023 · BURLINGTON, Mass., Feb. 3, 2023 / PRNewswire / -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has acquired Ziath, Ltd. and its subsidiaries ("Ziath"). Based in Cambridge, UK, Ziath is a leading provider of 2D barcode readers for life sciences applications. Founded in 2005, Ziath's innovative 2D barcode readers are a key component of the ... Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech ...

On May 9, 2022, Azenta, Inc. (“Azenta” or the “Company”) announced via press release its preliminary financial results for the fiscal quarter ended March 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1. Limitation on Incorporation by Reference. The information in this Item 2.02 and in Item 9.01 of this Current ...

Nov 14, 2023 · Thank you, operator, and good afternoon to everyone on the line today. We would like to welcome you to our earnings conference call for the fourth quarter of fiscal year 2023. Our fourth quarter ...

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.Chelmsford, MA – September 28, 2021 – Today Brooks Automation, Inc. (Nasdaq: BRKS) announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences (“Azenta”). Azenta will bring together our existing portfolio of life sciences products and services to deliver ...Azenta (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold ...View the latest Azenta Inc. (AZTA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Shares of Azenta, Inc. AZTA rose on Tuesday after the company reported better-than-expected fourth-quarter financial results. Azenta posted adjusted earnings of 13 cents per share, beating market ...AZTA Earnings Date and Information. Azenta last issued its quarterly earnings results on November 13th, 2023. The reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.12. The company earned $165.95 million during the quarter, compared to analyst estimates of $163.91 million.

FORM 4. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP. Filed pursuant to Section 16 (a) of the Securities Exchange Act of 1934. or Section 30 (h) of the Investment Company Act of 1940. OMB APPROVAL. OMB Number: 3235-0287.Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.Webull offers Azenta Inc stock information, including NASDAQ: AZTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZTA stock news, and many more online research tools to …For assistance in the application process, please reach out to [email protected] or call (978) 262-2400. Review EEO Poster Know Your Rights: WOrkplace Discrimination is Illegal (dol.gov) Azenta Life Sciences participates in E-Verify®, and will provide the United States Federal Government with your form I-9 information to confirm you are ...Reported on 11/13/23. Get the latest Azenta Inc (AZTA) real-time quote, historical performance, charts, and other financial information to help you make more informed …Hayward Pool Products Inc has been a leader in the swimming pool industry for over 90 years. Founded in 1925, Hayward has been committed to providing innovative and high-quality products for residential and commercial pools.

Azenta, Inc. is a provider of life science sample exploration and management solutions for the life sciences market. The Company operates through two segments. The Life Sciences Products segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling ...Sep 20, 2021 · Azenta undertakes no obligation to update the information contained in this press release. INVESTOR CONTACTS: Sara Silverman Director, Investor Relations Azenta, Inc. 978.262.2635 [email protected]. Sherry Dinsmore Azenta, Inc. 978.262.2400 [email protected]

Azenta (AZTA). Company Profile. azenta (nasdaq: azta) is a leading provider ...Genomics Headquarters. 115 Corporate Boulevard, South Plainfield, NJ 07080 | +1-908-222-0711 | +1-908-333-4511Hayward Pool Products Inc. is a leading manufacturer and distributor of swimming pool equipment and supplies. With over 80 years of experience, the company has been at the forefront of innovation in the swimming pool industry.Azenta, Inc. announced that Herman Cueto will join Azenta as Chief Financial Officer, effective October 16, 2023. Mr. Cueto, who comes from BD , will succeed Azenta CFO Lindon Robertson, who is...Still, Azenta’s stock popped +14% today as Q4 sales of $172.36 million beat estimates by 5% and rose 25% from $137.57 million in the comparative quarter. Azenta’s stock currently sports a Zack ...Open Filing by person (s) reporting owned shares of common stock in a public company >5% in PDF file. Open Filing by person (s) reporting owned shares of common stock in a public company >5% in XLS file. 3. Initial filing by director officer or owner of more than ten percent. Aug 31, 2023.Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services ...AZENTA INC: Códigos de Negociação: Mais Códigos A2ZT34. A2ZT34 Códigos ISIN: BRA2ZTBDR008 Códigos CVM: 58076. CNPJ: 00.000.000/0000-00: Atividade Principal: Classificação Setorial: Não Classificados / Não Classificado / Não Classificados: Contatos. Plantão de Notícias delay de 15 min.

Aug 9, 2022 · Azenta undertakes no obligation to update the information contained in this press release. About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster.

Currently, Azenta Inc does not have a price-earnings ratio. Azenta Inc’s trailing 12-month revenue is $665.1 million with a -2.1% net profit margin. Year-over-year quarterly sales growth most recently was 25.3%. Analysts expect adjusted earnings to reach $0.233 per share for the current fiscal year. Azenta Inc does not currently pay a dividend.

CHELMSFORD, Mass., September 26, 2018 (PRNEWSWIRE) -- Azenta Life Sciences, formerly a division of Brooks Automation, Inc. (Nasdaq: BRKS) today announced that it has entered into a definitive agreement to acquire GENEWIZ Group, a leading global genomics service provider headquartered in South Plainfield, New Jersey.The total cash …united states. securities and exchange commission. washington, d.c. 20549 form 8-k. current report. pursuant to section 13 or 15(d) of the securities exchange act of 1934FORM 8-K. CURRENT REPORT. PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Date of Report (Date of earliest event reported): January 24, 2022 Azenta, Inc.May 10, 2023 · Azenta, Inc. (NASDAQ:NASDAQ:AZTA) Q2 2023 Earnings Conference Call May 9, 2023 4:30 PM ETCompany ParticipantsSara Silverman - Head, IR & Corporate... Azenta Stock Performance. Shares of AZTA stock opened at $55.16 on Tuesday. The stock’s 50-day moving average is $49.60 and its two-hundred day moving average is $48.18. The firm has a market cap of $3.32 billion, a price-to-earnings ratio of -306.43 and a beta of 1.52. Azenta has a 1 year low of $36.01 and a 1 year high of $63.60.As announced at its recent investor day, Brooks Automation, Inc is changing its name to Azenta, Inc. and will begin trading on Nasdaq under the ticker symbol AZTA, effective at the open of market ...AZENTA, INC. (Exact name of registrant as specified in its charter) ...Azenta, Inc. is a provider of life science sample exploration and management solutions for the life sciences market. The Company operates through two segments. The Life Sciences Products segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling ...

Hayward Pool Products Inc has been a leader in the swimming pool industry for over 90 years. Founded in 1925, Hayward has been committed to providing innovative and high-quality products for residential and commercial pools.Currently, Azenta Inc does not have a price-earnings ratio. Azenta Inc’s trailing 12-month revenue is $665.1 million with a -2.1% net profit margin. Year-over-year quarterly sales growth most recently was 25.3%. Analysts expect adjusted earnings to reach $0.233 per share for the current fiscal year. Azenta Inc does not currently pay a dividend.Nov 27, 2023 · Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services ... Webull offers Azenta Inc stock information, including NASDAQ: AZTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZTA stock news, and many more online research tools to …Instagram:https://instagram. nanodimensionuyg stock pricebest commodities etfis aetna good medical insurance Safari is a popular web browser developed by Apple Inc. Known for its sleek design and seamless user experience, Safari has grown to become one of the most widely used browsers across various devices. nope etftop performing mutual funds 2023 Orbit Irrigation Products, Inc. commonly referred to as simply Orbit, produces irrigation products for residential and commercial home and garden use. Occasionally, you may need to reference one of Orbit’s product manuals for the proper use... sofi valuation Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2023 earnings which ended on March 31, 2023 on Tuesday, May 9, 2023 after the market closes.Azenta, Inc. (NasdaqGS:AZTA) entered into an agreement to acquire B Medical Systems S.à R.L. from Navis Capital Partners for approximately €460 million on August 8, 2022. Under the terms, the cash purchase price to be paid at closing will be approximately €410 million.